Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 6983

1.

Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.

Sarver P, Acker M, Bagdanoff JT, Chen Z, Chen YN, Chan H, Firestone B, Fodor M, Fortanet J, Hao H, Hentemann M, Jouk A, Kato M, Koenig R, LaBonte LR, Liu G, Liu S, Liu C, McNeill E, Mohseni M, Shultz MD, Sendzik M, Stams T, Spence S, Tamez V, Tichkule R, Towler C, Wang H, Wang P, Williams SL, Yu B, LaMarche MJ.

J Med Chem. 2019 Mar 22. doi: 10.1021/acs.jmedchem.9b00436. [Epub ahead of print] No abstract available.

PMID:
30900883
2.

Correction to Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.

Bagdanoff JT, Chen Z, Acker M, Chen YN, Chan H, Dore M, Firestone B, Fodor M, Fortanet J, Hentemann M, Kato M, Koenig R, LaBonte LR, Liu S, Mohseni M, Ntaganda R, Sarver P, Shultz MD, Smith T, Sendzik M, Stams T, Spence S, Towler C, Wang H, Wang P, Williams SL, LaMarche MJ.

J Med Chem. 2019 Mar 22. doi: 10.1021/acs.jmedchem.9b00435. [Epub ahead of print] No abstract available.

PMID:
30900881
3.

Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Kato M, Natarajan R.

Nat Rev Nephrol. 2019 Mar 20. doi: 10.1038/s41581-019-0135-6. [Epub ahead of print] Review.

PMID:
30894700
4.

Sequential Ubiquitination of Ribosomal Protein uS3 Triggers the Degradation of Non-functional 18S rRNA.

Sugiyama T, Li S, Kato M, Ikeuchi K, Ichimura A, Matsuo Y, Inada T.

Cell Rep. 2019 Mar 19;26(12):3400-3415.e7. doi: 10.1016/j.celrep.2019.02.067.

PMID:
30893611
5.

Electrophoretic fabrication of an active and selective wrinkle surface on hydrogels.

Kato M, Asoh TA, Uyama H.

Chem Commun (Camb). 2019 Mar 20. doi: 10.1039/c9cc01307e. [Epub ahead of print]

PMID:
30892314
6.

TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.

Amalia R, Abdelaziz M, Puteri MU, Hwang J, Anwar F, Watanabe Y, Kato M.

Cell Signal. 2019 Mar 16. pii: S0898-6568(19)30059-2. doi: 10.1016/j.cellsig.2019.03.016. [Epub ahead of print]

PMID:
30890370
7.

Urodynamic analysis of the impact of diabetes mellitus on bladder function.

Majima T, Matsukawa Y, Funahashi Y, Takai S, Kato M, Yamamoto T, Gotoh M.

Int J Urol. 2019 Mar 18. doi: 10.1111/iju.13935. [Epub ahead of print]

PMID:
30887604
8.

Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.

Nishio Y, Sakai H, Saiki Y, Uchida A, Uemura Y, Matsunawa M, Isobe Y, Kato M, Tomita N, Miura I.

Int J Hematol. 2019 Mar 18. doi: 10.1007/s12185-019-02629-7. [Epub ahead of print]

PMID:
30887274
9.

The Application of Virtual Reality for Preoperative Planning of Lymphovenous Anastomosis in a Patient with a Complex Lymphatic Malformation.

Giacalone G, Yamamoto T, Belva F, Hayashi A, Dori Y, Zviman MM, Gysen M, Nam HH, Jolley MA, Kato M.

J Clin Med. 2019 Mar 15;8(3). pii: E371. doi: 10.3390/jcm8030371.

10.

Optimal cutoff value of bipolar low-voltage in electroanatomic voltage mapping during atrial fibrillation rhythm.

Kawaji T, Hojo S, Kushiyama A, Nakatsuma K, Kaneda K, Kato M, Yokomatsu T, Miki S.

Pacing Clin Electrophysiol. 2019 Mar 15. doi: 10.1111/pace.13661. [Epub ahead of print]

PMID:
30873619
11.

PMEPA1/TMEPAI knockout impairs tumor growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth.

Abdelaziz M, Watanabe Y, Kato M.

J Biochem. 2019 Mar 14. pii: mvz022. doi: 10.1093/jb/mvz022. [Epub ahead of print]

PMID:
30873542
12.

TAS-121, a selective mutant EGFR inhibitor, shows activity against tumors expressing various EGFR mutations including T790M and uncommon mutations G719X.

Ito K, Nishio M, Kato M, Murakami H, Aoyagi Y, Ohe Y, Okayama T, Hashimoto A, Ohsawa H, Tanaka G, Nonoshita K, Ito S, Matsuo K, Miyadera K.

Mol Cancer Ther. 2019 Mar 14. pii: molcanther.0645.2018. doi: 10.1158/1535-7163.MCT-18-0645. [Epub ahead of print]

PMID:
30872380
13.

Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.

Ikeda J, Shiba N, Tsujimoto SI, Yoshida M, Nakabayashi K, Ogata-Kawata H, Okamura K, Takeuchi M, Osumi T, Tomizawa D, Hata K, Kiyokawa N, Ito S, Kato M.

Genes Chromosomes Cancer. 2019 Mar 14. doi: 10.1002/gcc.22751. [Epub ahead of print]

PMID:
30869817
14.

Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials.

Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T.

J Bone Miner Metab. 2019 Mar 13. doi: 10.1007/s00774-018-00985-8. [Epub ahead of print]

PMID:
30868270
15.

Robust Triplatinum Redox-chromophore for a Post-synthetic Color-tunable Electrochromic System.

Yoshida M, Shitama H, Sameera WMC, Kobayashi A, Kato M.

Chemistry. 2019 Mar 13. doi: 10.1002/chem.201900713. [Epub ahead of print]

PMID:
30865326
16.

Quantitative Solvent-Free Thermal Synthesis of Luminescent Cu(I) Coordination Polymers.

Kobayashi A, Fujii M, Shigeta Y, Yoshida M, Kato M.

Inorg Chem. 2019 Mar 13. doi: 10.1021/acs.inorgchem.8b03641. [Epub ahead of print]

PMID:
30864431
17.

Circulating Plasmablasts Contribute to Antiphospholipid Antibody Production, Associated with Type I Interferon Upregulation.

Hisada R, Kato M, Sugawara E, Kanda M, Fujieda Y, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T.

J Thromb Haemost. 2019 Mar 12. doi: 10.1111/jth.14427. [Epub ahead of print]

PMID:
30864219
18.

Phosphorescence at Low Temperature by External Heavy-Atom Effect in Zinc(II) Clusters.

Kobayashi F, Ohtani R, Teraoka S, Yoshida M, Kato M, Zhang Y, Lindoy LF, Hayami S, Nakamura M.

Chemistry. 2019 Mar 12. doi: 10.1002/chem.201900343. [Epub ahead of print]

PMID:
30860310
19.

Measurement of the absolute number of photons of the hard X-ray beamline at the Linac Coherent Light Source.

Song S, Alonso-Mori R, Chollet M, Feng Y, Glownia JM, Lemke HT, Sikorski M, Zhu D, Moeller S, Lee HJ, Hunter MS, Carini G, Tiedtke K, Jastrow U, Sorokin A, Richter M, Owada S, Tono K, Saito N, Tanaka T, Kato M, Yabashi M, Robert A.

J Synchrotron Radiat. 2019 Mar 1;26(Pt 2):320-327. doi: 10.1107/S1600577519000250. Epub 2019 Feb 11.

PMID:
30855238
20.

Prevalence and Significance of Restless Legs Syndrome in Patients With Coronary Artery Disease.

Yatsu S, Kasai T, Suda S, Matsumoto H, Ishiwata S, Shiroshita N, Kato M, Kawana F, Murata A, Shimizu M, Shitara J, Kato T, Hiki M, Sai E, Miyauchi K, Daida H.

Am J Cardiol. 2019 Feb 23. pii: S0002-9149(19)30222-X. doi: 10.1016/j.amjcard.2019.02.017. [Epub ahead of print]

PMID:
30850211
21.

Glecaprevir and Pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study.

Ogawa E, Furusyo N, Nakamuta M, Nomura H, Satoh T, Takahashi K, Koyanagi T, Kajiwara E, Dohmen K, Kawano A, Ooho A, Azuma K, Kato M, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.

Hepatol Res. 2019 Mar 8. doi: 10.1111/hepr.13328. [Epub ahead of print]

PMID:
30849206
22.

For making a declaration of countermeasures against the falling birth rate from the Japanese Society for Hygiene: summary of discussion in the working group on academic research strategy against an aging society with low birth rate.

Nomura K, Karita K, Araki A, Nishioka E, Muto G, Iwai-Shimada M, Nishikitani M, Inoue M, Tsurugano S, Kitano N, Tsuji M, Iijima S, Ueda K, Kamijima M, Yamagata Z, Sakata K, Iki M, Yanagisawa H, Kato M, Inadera H, Kokubo Y, Yokoyama K, Koizumi A, Otsuki T.

Environ Health Prev Med. 2019 Mar 5;24(1):14. doi: 10.1186/s12199-019-0768-x.

23.

[Infected Pelvic Lymphocele after Robot-Assisted Radical Prostatectomy].

Murata D, Mita K, Nomura N, Kobatake K, Ohara S, Kato M, Mochizuki H.

Hinyokika Kiyo. 2019 Jan;65(1):1-6. doi: 10.14989/ActaUrolJap_65_1_1. Japanese.

PMID:
30831670
24.

[Robot-Assisted Partial Nephrectomy for Renal Tumor ≤7 cm in Diameter].

Mita K, Nomura N, Murata D, Ohara S, Kato M, Mochizuki H.

Hinyokika Kiyo. 2018 Dec;64(12):477-482. doi: 10.14989/ActaUrolJap_64_12_477. Japanese.

PMID:
30831662
25.

First-in-Asian Phase I Study of the Anti-Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X-linked Hypophosphatemia.

Cheong HI, Yoo HW, Adachi M, Tanaka H, Fujiwara I, Hasegawa Y, Harada D, Sugimoto M, Okada Y, Kato M, Shimazaki R, Ozono K, Seino Y.

JBMR Plus. 2018 Sep 14;3(2):e10074. doi: 10.1002/jbm4.10074. eCollection 2019 Feb.

26.

Combined analysis of near-infrared spectra, colour, and physicochemical information of brown rice to develop accurate calibration models for determining amylose content.

Olivares Díaz E, Kawamura S, Matsuo M, Kato M, Koseki S.

Food Chem. 2019 Jul 15;286:297-306. doi: 10.1016/j.foodchem.2019.02.005. Epub 2019 Feb 8.

PMID:
30827610
27.

Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2019 Feb 28. doi: 10.1111/iju.13911. [Epub ahead of print]

PMID:
30818424
28.

Flow Pattern Classification in Lymphatic Malformations by Indocyanine Green Lymphography.

Kato M, Watanabe S, Iida T, Watanabe A.

Plast Reconstr Surg. 2019 Mar;143(3):558e-564e. doi: 10.1097/PRS.0000000000005362.

PMID:
30817659
29.

Visit-to-visit blood pressure variability and a risk of diabetic foot ulcers: how calcium channel blockers moderate?

Nagai M, Dote K, Kato M, Oda N, Kunita E.

J Hypertens. 2019 Apr;37(4):860-861. doi: 10.1097/HJH.0000000000002043. No abstract available.

PMID:
30817469
30.

How to manage pediatric oncologic emergencies: Imaging diagnosis.

Kato M.

Pediatr Int. 2019 Feb;61(2):121. doi: 10.1111/ped.13790. No abstract available.

PMID:
30809880
31.

Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia.

Tsumura Y, Yamada Y, Osumi T, Kato M, Terashima K, Shioda Y, Kiyotani C, Matsumoto K, Tomizawa D.

J Pediatr Hematol Oncol. 2019 Feb 22. doi: 10.1097/MPH.0000000000001438. [Epub ahead of print]

PMID:
30807394
32.

An elevated neutrophil-to-lymphocyte ratio predicts a poor postoperative survival in primary hepatocellular carcinoma patients with a normal preoperative serum level of alpha-fetoprotein.

Shiraki T, Ishizuka M, Kubota K, Kato M, Matsumoto T, Mori S, Shimizu T, Aoki T.

Surg Today. 2019 Feb 26. doi: 10.1007/s00595-019-01781-1. [Epub ahead of print]

PMID:
30806789
33.

Chronological change of renal pathological findings in the proliferative glomerulonephritis with monoclonal IgG deposits considered to have recurred early after kidney transplantation.

Katsuno T, Kato M, Fujita T, Tsuboi N, Hattori R, Ito Y, Maruyama S.

CEN Case Rep. 2019 Feb 25. doi: 10.1007/s13730-019-00384-6. [Epub ahead of print]

34.

The hydrodynamic motion of Nanodiscs.

Camp T, McLean M, Kato M, Cheruzel L, Sligar S.

Chem Phys Lipids. 2019 Feb 22;220:28-35. doi: 10.1016/j.chemphyslip.2019.02.008. [Epub ahead of print]

PMID:
30802435
35.

Association of Thyrotropin Concentration with Chronic Kidney Disease in a Japanese General Population Cohort.

Toda A, Hara S, Kato M, Tsuji H, Arase Y.

Nephron. 2019 Feb 22:1-7. doi: 10.1159/000497326. [Epub ahead of print]

PMID:
30799424
36.

Inhibition of mast cell degranulation by melanin.

Kawamoto Y, Kondo H, Hasegawa M, Kurimoto C, Ishii Y, Kato C, Botei T, Shinya M, Murate T, Ueno Y, Kawabe M, Goto Y, Yamamoto R, Iida M, Yajima I, Ohgami N, Kato M, Takeda K.

Biochem Pharmacol. 2019 Feb 20;163:178-193. doi: 10.1016/j.bcp.2019.02.015. [Epub ahead of print]

PMID:
30796915
37.

Chemoradiotherapy could improve overall survival of patients with stage IV cutaneous squamous cell carcinoma: analysis of 34 cases.

Hiura A, Yoshino K, Maeda T, Nagai K, Oaku S, Kato M, Fujisawa Y.

Br J Dermatol. 2019 Feb 21. doi: 10.1111/bjd.17792. [Epub ahead of print]

PMID:
30791086
38.

Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.

Noguchi A, Yasuda S, Hisada R, Kato M, Oku K, Bohgaki T, Suzuki M, Matsumoto Y, Atsumi T.

Mod Rheumatol. 2019 Feb 21:1-6. doi: 10.1080/14397595.2019.1583784. [Epub ahead of print]

PMID:
30789096
39.

Short- and long-term outcomes of endoscopically treated superficial non-ampullary duodenal epithelial tumors.

Hara Y, Goda K, Dobashi A, Ohya TR, Kato M, Sumiyama K, Mitsuishi T, Hirooka S, Ikegami M, Tajiri H.

World J Gastroenterol. 2019 Feb 14;25(6):707-718. doi: 10.3748/wjg.v25.i6.707.

40.

Single-step colony assay with autoinduction of scFv expression for the screening of antibody libraries.

Kato M, Hanyu Y.

Biotechniques. 2019 Feb 20. doi: 10.2144/btn-2018-0195. [Epub ahead of print]

41.

Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies.

Matsukawa Y, Takai S, Majima T, Funahashi Y, Sassa N, Kato M, Yamamoto T, Gotoh M.

Neurourol Urodyn. 2019 Feb 19. doi: 10.1002/nau.23935. [Epub ahead of print]

PMID:
30779375
42.

Metachronous gastric cancer risk after endoscopic resection of early gastric cancer and H. pylori status.

Kato M.

J Gastroenterol. 2019 Feb 15. doi: 10.1007/s00535-019-01560-2. [Epub ahead of print] No abstract available.

PMID:
30770974
43.

Analgesic effects of mirogabalin, a novel ligand for α2δ subunit of voltage-gated calcium channels, in experimental animal models of fibromyalgia.

Saeki K, Yasuda SI, Kato M, Kano M, Domon Y, Arakawa N, Kitano Y.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Feb 15. doi: 10.1007/s00210-019-01628-z. [Epub ahead of print]

PMID:
30770951
44.

Hip Arthrography Complicated by Air Embolism in Infants: A Report of 2 Cases.

Bell C, Greene N, Kato M, Goldstein R, Yang S.

JBJS Case Connect. 2019 Feb 13. doi: 10.2106/JBJS.CC.18.00083. [Epub ahead of print]

PMID:
30762594
45.

Anemia in Patients with Severe Aortic Stenosis.

Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators.

Sci Rep. 2019 Feb 13;9(1):1924. doi: 10.1038/s41598-018-36066-z.

46.

Biologic-induced urticaria due to polysorbate 20.

Kato M, Oiso N, Uchida S, Yanagihara S, Sano H, Tohda Y, Kawada A.

J Dermatol. 2019 Feb 13. doi: 10.1111/1346-8138.14808. [Epub ahead of print] No abstract available.

PMID:
30758866
47.

Chemoselective Nucleophilic Functionalizations of Aromatic Aldehydes and Acetals via Pyridinium Salt Intermediates.

Kawajiri T, Kato M, Nakata H, Goto R, Aibara SY, Ohta R, Fujioka H, Sajiki H, Sawama Y.

J Org Chem. 2019 Feb 20. doi: 10.1021/acs.joc.8b02965. [Epub ahead of print]

PMID:
30747527
48.

Age-stratified sex differences in polysomnographic findings and pharyngeal morphology among children with obstructive sleep apnea.

Inoshita A, Kasai T, Matsuoka R, Sata N, Shiroshita N, Kawana F, Kato M, Ikeda K.

J Thorac Dis. 2018 Dec;10(12):6702-6710. doi: 10.21037/jtd.2018.11.09.

49.

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.

Sunami K, Ichikawa H, Kubo T, Kato M, Fujiwara Y, Shimomura A, Koyama T, Kakishima H, Kitami M, Matsushita H, Furukawa E, Narushima D, Nagai M, Taniguchi H, Motoi N, Sekine S, Maeshima A, Mori T, Watanabe R, Yoshida M, Yoshida A, Yoshida H, Satomi K, Sukeda A, Hashimoto T, Shimizu T, Iwasa S, Yonemori K, Kato K, Morizane C, Ogawa C, Tanabe N, Sugano K, Hiraoka N, Tamura K, Yoshida T, Fujiwara Y, Ochiai A, Yamamoto N, Kohno T.

Cancer Sci. 2019 Feb 11. doi: 10.1111/cas.13969. [Epub ahead of print]

50.

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study.

Iguchi T, Tamada S, Kato M, Yasuda S, Otoshi T, Hamada K, Yamasaki T, Nakatani T.

Int J Clin Oncol. 2019 Feb 11. doi: 10.1007/s10147-019-01413-1. [Epub ahead of print]

PMID:
30741370

Supplemental Content

Support Center